A new influenza vaccine developed in Japan is sprayed into the nose. It takes advantage of mucosal immunity in the nose and mouth to stop infection. It has a low risk of side effects and can be used on infants and the elderly. Injected vaccines aim to stop an infection from worsening. They cannot prevent infection itself, but the nasal spray can. The nasal spray vaccine has completed all clinical trials and has the potential to be adapted for use against the new coronavirus.
The new vaccine triggers the production of antibodies that attack viruses on the membranes
The developer of the new vaccine says it can be adapted for use against the new coronavirus
There's a possibility the "factor x" that prevents COVID-19 from becoming severe in some patients is mucosal immunity
We introduce simple massages that boost mucosal immunity